Abstract
Presentation given by Kathleen Dooling on November 23rd 2020 to decide on select groups for COVID-19 vaccine allocation in Phase 1a, Phase 1b & Phase 1c
Background paper
Americas
United States of America
COVID-19
Presentation given by Kathleen Dooling on November 23rd 2020 to decide on select groups for COVID-19 vaccine allocation in Phase 1a, Phase 1b & Phase 1c
